Harnessing Ribonucleoprotein Granule Biology for Cancer Therapy: The Central Role of Protein Modifications

Dengxiong Li1, Qingxin Yu2,3, Ruicheng Wu4,5

  • 1Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.

Research (Washington, D.C.)
|February 20, 2026
PubMed

Insights

Ribonucleoprotein (RNP) granule modifications, like phosphorylation and acetylation, impact cancer development and treatment. Understanding these protein modifications is key for advancing RNP-based cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Aberrant ribonucleoprotein (RNP) granule expression and function are implicated in cancer initiation, progression, and treatment response.
  • Protein modifications play a crucial role in mediating interactions between cancer and RNP granules or associated proteins.

Purpose of the Study:

  • To summarize and discuss the intricate interactions between RNPs and various protein modifications within the context of cancer.
  • To facilitate the clinical translation of RNP-based therapies by elucidating these complex molecular mechanisms.

Main Methods:

  • Literature review and synthesis of existing studies on RNP modifications in cancer.
  • Analysis of reported protein modifications affecting RNP granules, including phosphorylation, ubiquitination, SUMOylation, methylation, crotonylation, and acetylation.
  • Identification of modifications not yet reported on RNPs, such as glycosylation, fucosylation, and PARylation.

Main Results:

  • RNPs can undergo several types of protein modifications, including phosphorylation, ubiquitination, SUMOylation, methylation, crotonylation, and acetylation.
  • These modifications can occur competitively on RNPs, influencing RNP granule expression and function.
  • RNP granule modifications are observed in cancer cells, immune cells, and stromal cells, impacting therapeutic efficacy.

Conclusions:

  • Protein modifications on RNP granules offer a basis for developing novel antitumor therapies.
  • The structural complexity of RNPs and the current depth of research present significant challenges for clinical translation of RNP-based strategies.

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K